Literature DB >> 19497373

Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model.

Stefan B Rowny1, Yael M Cycowicz, Shawn M McClintock, Matthew D Truesdale, Bruce Luber, Sarah H Lisanby.   

Abstract

Electroconvulsive therapy (ECT) is an effective treatment for severe depression; however, the induced therapeutic seizure acts on the autonomic nervous system and results in significant cardiac effects. This is an important consideration particularly in the elderly. Magnetic seizure therapy (MST) is in development as a less invasive alternative, but its effects on cardiac function have not been studied. We sought to model those effects in nonhuman primates to inform the development of safer neurostimulation interventions. Twenty four rhesus monkeys were randomly assigned to receive 6 weeks of daily treatment with electroconvulsive stimulation (ECS), magnetic seizure therapy (MST) or anesthesia-alone sham. Digitally acquired ECG and an automated R-wave and inter-R interval (IRI) sampling were used to measure intervention effects on heart rate (HR). Significant differences between experimental conditions were found in the HR as evidenced by changes in the immediate post-stimulus, ictal and postictal epochs. Immediate post-stimulus bradycardia was seen with ECS but not with MST. ECS induced significantly more tachycardia than MST or sham in both the ictal and postictal periods. MST resulted in a small, but statistically significant increase in HR during the postictal period relative to baseline. HR was found to increase by 25% and 8% in the ECS and MST conditions, respectively. MST resulted in significantly less marked sympathetic and parasympathetic response than did ECS. This differential physiological response is consistent with MST having a more superficial cortical site of action with less impact on deeper brain structures implicated in cardiac control relative to ECT. The clinical relevance of the topographical seizure spread of MST and its associated effects on the autonomic nervous system remain to be determined in human clinical trials.

Entities:  

Mesh:

Year:  2009        PMID: 19497373      PMCID: PMC3674813          DOI: 10.1016/j.neuroimage.2009.05.070

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  32 in total

1.  Relationship between depression and other medical illnesses.

Authors:  S P Roose; A H Glassman; S N Seidman
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

Review 2.  Electroconvulsive therapy for depression.

Authors:  Sarah H Lisanby
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

3.  Efficiency of the stimulus characteristics of ECT.

Authors:  C M Swartz; D T Manly
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

4.  ECT in the High-Risk Geriatric Patient.

Authors:  George S. Alexopoulos; Robert C. Young; Robert C. Abrams
Journal:  Convuls Ther       Date:  1989

5.  Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.

Authors:  Sarah H Lisanby; Bruce Luber; Thomas E Schlaepfer; Harold A Sackeim
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

6.  Quick recovery of orientation after magnetic seizure therapy for major depressive disorder.

Authors:  George Kirov; Klaus P Ebmeier; Allan I F Scott; Maria Atkins; Najeeb Khalid; Lucy Carrick; Andrew Stanfield; Ronan E O'Carroll; Mustafa M Husain; Sarah H Lisanby
Journal:  Br J Psychiatry       Date:  2008-08       Impact factor: 9.319

7.  Acute effects of ECT on cardiovascular functioning: relations to patient and treatment variables.

Authors:  J Prudic; H A Sackeim; P Decina; N Hopkins; F R Ross; S Malitz
Journal:  Acta Psychiatr Scand       Date:  1987-04       Impact factor: 6.392

8.  Ventricular tachycardia with ECT.

Authors:  J R Larsen; L Hein; L S Strömgren
Journal:  J ECT       Date:  1998-06       Impact factor: 3.635

9.  Incidence of asystole in electroconvulsive therapy in elderly patients.

Authors:  J Burd; P Kettl
Journal:  Am J Geriatr Psychiatry       Date:  1998       Impact factor: 4.105

Review 10.  Depression and cardiovascular disease.

Authors:  A Glassman
Journal:  Pharmacopsychiatry       Date:  2008-12-09       Impact factor: 5.788

View more
  6 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

Review 3.  Update on Neuromodulation for Treatment-Resistant Depression.

Authors:  Bettina Bewernick; Thomas E Schlaepfer
Journal:  F1000Res       Date:  2015-12-02

4.  Cardiovascular Effects of High-Frequency Magnetic Seizure Therapy Compared With Electroconvulsive Therapy.

Authors:  Jun-Yan Zhang; Han Wu; Li-Na Jia; Wei Jiang; Jiong Luo; Yi Liu; Qi Gao; Yan-Ping Ren; Xin Ma; Yi-Lang Tang; William M McDonald
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

5.  Neuromodulation therapies and treatment-resistant depression.

Authors:  Khalid Saad Al-Harbi; Naseem Akhtar Qureshi
Journal:  Med Devices (Auckl)       Date:  2012-07-13

6.  Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy.

Authors:  Misako Kanayama; Tsuyoshi Miyaoka; Tomoko Araki; Maiko Hayashida; Sadayuki Hashioka; Jun Horiguchi
Journal:  Case Rep Psychiatry       Date:  2018-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.